New pill tested to help weakened hearts pump stronger

NCT ID NCT05642507

Summary

This early-stage study tested a new oral medication called AC01 in people with chronic heart failure where the heart pumps weakly. The main goals were to check if the drug was safe and to see how the body processes it. Researchers also looked for early signs that the drug might improve how well the heart functions.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Amsterdam University Medical Centre

    Amsterdam, 1081 HV, Netherlands

  • Azienda Sanitaria Universitaria Integrata

    Trieste, 34149, Italy

  • Erasmus Medical Centre

    Rotterdam, 3015 GD, Netherlands

  • Golden Jubilee National Hospital

    Glasgow, G81 4DY, United Kingdom

  • Karolinska University Hospital

    Stockholm, 171 76, Sweden

  • King's College Hospital

    London, SE5 9RS, United Kingdom

  • Maastricht Heart and Vascular Center

    Maastricht, 6229 HX, Netherlands

  • Ninewells Hospital and Medical School

    Dundee, DD1 9SY, United Kingdom

  • Sahlgrenska University Hospital

    Gothenburg, 413045, Sweden

  • Skånes Universitetssjukhus Lund

    Lund, 222 42, Sweden

  • Spedali Civilia di Brescia

    Brescia, 25123, Italy

  • University Medical Centre Groningen/ICON

    Groningen, 9718 GZ, Netherlands

  • University of Glasgow, Institute of Cardiovascular & Medical Sciences

    Glasgow, G12 8QQ, United Kingdom

Conditions

Explore the condition pages connected to this study.